Skip to content
Inciteful Med

Women's Health: Managing Periods and Pregnancy with GT

Last updated:

Women with Glanzmann Thrombasthenia (GT) manage heavy menstrual bleeding using antifibrinolytics like tranexamic acid or hormonal suppression to stop periods. Pregnancy requires a multidisciplinary team to prevent postpartum hemorrhage and monitor for Neonatal Alloimmune Thrombocytopenia (NAIT) in the baby.

Key Takeaways

  • • Heavy menstrual bleeding is a common symptom often treated by suppressing periods with hormones.
  • • Pregnancy is high-risk and requires a multidisciplinary team including a hematologist and high-risk OB.
  • • Postpartum hemorrhage is the primary risk to the mother, managed with tranexamic acid and rFVIIa.
  • • Maternal antibodies can cause temporary low platelets in the baby (NAIT), which requires monitoring.
  • • Iron supplementation is crucial for preventing anemia caused by chronic menstrual blood loss.

Women and girls with Glanzmann Thrombasthenia (GT) face unique medical challenges, particularly concerning reproductive health. Because GT affects the body’s “hooks” for clotting, areas with high blood flow—like the uterus during menstruation or childbirth—require specialized, proactive management [1][2].

Managing Heavy Menstrual Bleeding (Menorrhagia)

Heavy menstrual bleeding (HMB) is one of the most common and taxing symptoms for women with GT [3][4]. The goal of treatment is often to reduce or entirely stop the period to prevent chronic anemia and emergency hospital visits [5][3].

The Treatment Ladder for Periods

  1. Antifibrinolytics (The Clot Preservers): Medications like tranexamic acid (TXA) are often the first line of defense. They are taken only during the menstrual cycle to help the body keep the clots it forms from dissolving too quickly [1][6].
  2. Hormonal Suppression: The most effective long-term strategy for many is amenorrhea (stopping the period entirely) [5][3].
    • Oral Contraceptives: Combined or progesterone-only pills can help thin the uterine lining [1][2].
    • Injections and Implants: Options like Depo-Provera or hormonal implants can provide long-lasting suppression [1].
    • Mirena IUD: This hormonal intrauterine device can significantly reduce bleeding, but the insertion itself can cause a bleed that must be managed by a hematologist [7].
  3. Iron Supplementation: Because of regular blood loss, many women with GT develop iron deficiency anemia [8][9]. Regular monitoring of iron and ferritin levels is essential to prevent fatigue and other complications [8].

Pregnancy and Delivery

Pregnancy in GT is considered high-risk and requires a multidisciplinary team including a hematologist and a maternal-fetal medicine (high-risk OB) specialist [10][11].

Risks to the Mother

The primary risk is Postpartum Hemorrhage (PPH), or severe bleeding after delivery [12][1]. To manage this, doctors often use a combination of:

  • Tranexamic acid during and after labor [12][10].
  • rFVIIa (NovoSeven) to provide an extra “thrombin burst” during delivery [12][1].
  • Uterotonics, which are medications that help the uterus contract and close off blood vessels after birth [12].

Risks to the Baby: Understanding NAIT

If a mother has developed antibodies (alloimmunization) against the “hooks” (GPIIb/IIIa) on platelets, these antibodies can cross the placenta [13][14][11].

  • Neonatal Alloimmune Thrombocytopenia (NAIT): The mother’s antibodies can attack the baby’s platelets while they are still in the womb [13][11].
  • Temporary Condition: It is important to know that this low platelet count in the baby is usually temporary. The baby does not necessarily have GT; their platelets are just being attacked by the mother’s antibodies. Once those antibodies clear from the baby’s system (usually within a few weeks), their platelet count typically returns to normal [12][14].
  • Treatment: Mothers may receive IVIG (intravenous immunoglobulin) during pregnancy to protect the baby’s platelets if high levels of antibodies are detected [10][15].

Planning Ahead

For women with GT, the “best” delivery is a planned delivery. This ensures all necessary medications (like rFVIIa) and specialists are in the room the moment they are needed [12][10].

Frequently Asked Questions

How is heavy menstrual bleeding treated in Glanzmann Thrombasthenia?
Heavy periods are typically managed with antifibrinolytics like tranexamic acid to preserve clots, or hormonal suppression (pills, implants, or IUDs) to stop menstruation entirely. Iron supplementation is also used to treat anemia caused by blood loss.
Is pregnancy safe for women with Glanzmann Thrombasthenia?
Pregnancy with GT is considered high-risk due to the potential for severe bleeding during and after delivery. However, with a specialized team including a hematologist and high-risk obstetrician, most women can have safe outcomes.
What is Neonatal Alloimmune Thrombocytopenia (NAIT)?
NAIT occurs when a mother's antibodies attack her baby's platelets in the womb, causing a temporary low platelet count in the newborn. It usually resolves within a few weeks after birth as the mother's antibodies clear from the baby's system.
What medications are used during delivery to prevent bleeding?
Doctors often use tranexamic acid and recombinant Factor VIIa (NovoSeven) during labor to help blood clot. Uterotonics are also used to help the uterus contract and stop bleeding after the baby is delivered.
Can I use an IUD if I have a bleeding disorder?
Yes, hormonal IUDs like Mirena can be very effective at reducing menstrual bleeding. However, the insertion procedure can cause bleeding, so it must be managed carefully by a hematologist.

Questions for Your Doctor

  • • What is the most effective hormonal method to achieve amenorrhea (stopping my period) while minimizing the risk of a bleed during insertion or transition?
  • • Should we start iron supplementation now to prevent anemia, even if my current hemoglobin levels are normal?
  • • How often should we monitor for anti-platelet antibodies during pregnancy to assess the risk for the baby?
  • • Can we create a written delivery plan that includes the use of rFVIIa (NovoSeven) and tranexamic acid to prevent postpartum hemorrhage?
  • • If the baby is at risk for neonatal alloimmune thrombocytopenia (NAIT), will we need to plan for a C-section or special neonatal care?

Questions for You

  • • How many pads or tampons do I typically go through during a heavy day of my period?
  • • Have I ever felt lightheaded, extremely tired, or short of breath during my period, which might indicate anemia?
  • • If I have an IUD or am considering one, did my doctor discuss the specific risk of bleeding during the insertion procedure?
  • • How many members are currently on my care team (e.g., Hematologist, Gynecologist, High-Risk OB)?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Obstetric and Gynaecological Challenges and Outcomes in Women and Girls With Glanzmann's Thrombasthenia.

    Obeng-Tuudah D, Tarawah A, Ozkan M, Abdul-Kadir R

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(3)):509-518 doi:10.1111/hae.70030.

    PMID: 40123272
  2. 2

    Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center.

    Kasinathan G, Sathar J

    Blood research 2021; (56(4)):315-321 doi:10.5045/br.2021.2021165.

    PMID: 34916340
  3. 3

    Management of Severe Menorrhagia in an Adolescent with Glanzmann Thrombasthenia: A Case Report and Treatment Approach.

    Tiwari SK, Sonowal R, Bhowmick R, Joshi P

    Journal of pediatric and adolescent gynecology 2025; doi:10.1016/j.jpag.2025.11.008.

    PMID: 41265828
  4. 4

    Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects.

    Blaauwgeers MW, Kruip MJHA, Beckers EAM, et al.

    American journal of hematology 2020; (95(10)):1142-1147 doi:10.1002/ajh.25910.

    PMID: 32562285
  5. 5

    Management of Refractory Menstrual Bleeding in an Adolescent with Glanzmann Thrombasthenia: A Case Report and Review.

    King LJ, Huff J, Heber D, et al.

    Case reports in obstetrics and gynecology 2020; (2020()):8848763 doi:10.1155/2020/8848763.

    PMID: 33062357
  6. 6

    Glanzmann's thrombasthenia: a rare bleeding disorder in a Nigerian girl.

    Ezenwosu OU, Chukwu BF, Uwaezuoke NA, et al.

    African health sciences 2020; (20(2)):753-757 doi:10.4314/ahs.v20i2.27.

    PMID: 33163040
  7. 7

    Glanzmann Thrombasthenia: Use of the Soft Splint with Tranexamic Acid Paste to Reduce Spontaneous Oral Bleeding.

    Bhavyaa R, Vignesh KC, Muthu MS, et al.

    International journal of clinical pediatric dentistry 2021; (14(4)):580-585 doi:10.5005/jp-journals-10005-1973.

    PMID: 34824518
  8. 8

    Characterising Glanzmann Thrombasthenia in the United States: Real-World Data From the EPIC Cosmos Dataset.

    Citla-Sridhar D, Liu D

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; doi:10.1111/hae.70170.

    PMID: 41259300
  9. 9

    Dental Management of Seven-Year-Old Child With Glanzmann Thrombasthenia: A Case Report.

    Alduhayan G, Alsaif A, Almohareb R, Demyati M

    Cureus 2024; (16(9)):e70243 doi:10.7759/cureus.70243.

    PMID: 39463654
  10. 10

    Multidisciplinary management of a pregnancy complicated by Glanzmann thrombasthenia: A case report.

    Hernandez MM, Buckley A, Mills A, et al.

    Transfusion 2023; (63(12)):2384-2391 doi:10.1111/trf.17594.

    PMID: 37952246
  11. 11

    Glanzmann thrombasthenia: genetic basis and clinical correlates.

    Botero JP, Lee K, Branchford BR, et al.

    Haematologica 2020; (105(4)):888-894 doi:10.3324/haematol.2018.214239.

    PMID: 32139434
  12. 12

    Glanzmann's thrombasthenia in a twin pregnancy: A case report.

    Xu VX, Brennecke SP

    Case reports in women's health 2025; (46()):e00697 doi:10.1016/j.crwh.2025.e00697.

    PMID: 40161270
  13. 13

    How I manage pregnancy in women with Glanzmann thrombasthenia.

    Fiore M, Sentilhes L, d'Oiron R

    Blood 2022; (139(17)):2632-2641 doi:10.1182/blood.2021011595.

    PMID: 35286390
  14. 14

    Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes.

    Wijemanne A, Watt-Coote I, Austin S

    Obstetric medicine 2016; (9(4)):169-170 doi:10.1177/1753495X16655021.

    PMID: 27829878
  15. 15

    From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia.

    Barg AA, Hauschner H, Luboshitz J, et al.

    Pediatric blood & cancer 2018; (65(12)):e27376 doi:10.1002/pbc.27376.

    PMID: 30216638

This guide on managing periods and pregnancy with Glanzmann Thrombasthenia is for educational purposes. Always consult your hematologist and obstetrician for personalized care protocols.

Stay up to date

Get notified when new research about Glanzmann Thrombasthenia is published.

No spam. Unsubscribe anytime.